These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1234998)

  • 1. Investigations on partial synchronization in ascites tumors of different ploidy and in solid transplantable tumors.
    Lennartz KJ; Klein HO; Feaux de Lacroix W
    Recent Results Cancer Res; 1975; (52):179-86. PubMed ID: 1234998
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental and clinical results of chemotherapy after partial synchronization of cell proliferation.
    Klein HO; Gross R
    Recent Results Cancer Res; 1975; (52):215-24. PubMed ID: 1235001
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is in-vivo synchronization of cells possible with vincristine?].
    Schultze B
    Strahlentherapie Sonderb; 1978; 75():46-51. PubMed ID: 555054
    [No Abstract]   [Full Text] [Related]  

  • 4. Age-dependent change of the effect of a cytostatic drug on the proliferation kinetics of a solid tumor of the mouse.
    Feáux de Lacroix W; Weyer M; Schütt A; Lennartz KJ
    J Cancer Res Clin Oncol; 1979 May; 94(1):29-37. PubMed ID: 468897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synchronization of Ehrlich ascites tumor cells and its importance in the use of an alkylating cytostatic agent].
    Klein HO; Lennartz KJ; Habicht W; Eder M; Gross R
    Klin Wochenschr; 1970 Aug; 48(16):1001-5. PubMed ID: 5519404
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cellkinetic studies on Ehrlich-ascites tumor by treatment with vincristine].
    Hartenstein R; Ehrhart H; Hoffmann K
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1973 May; 79(3):213-20. PubMed ID: 4270227
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronobiological analysis of thyroxine action on cell proliferation in the hypotetraploid strain of Ehrlich's ascitic tumor].
    Romanov IuA; Stepanenko VA
    Biull Eksp Biol Med; 1989 Nov; 108(11):610-2. PubMed ID: 2633828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic investigations on a Ehrlich ascites tumor, and four sublines resistant to daunomycin, adriamycin, vincristine and vinblastine.
    Hasholt L; Dan0 K
    Hereditas; 1974; 77(2):303-10. PubMed ID: 4141349
    [No Abstract]   [Full Text] [Related]  

  • 9. Differentiation by colchicine and vincristine sulphate of regenerative hepatocellular mitosis and tumour-associated hepatocellular mitosis.
    Parry EW
    Gan; 1977 Oct; 68(5):681-4. PubMed ID: 590685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell kinetic alterations in normal and neoplastic cell populations in vitro and in vivo following vincristine: a reply to Dr Camplejohn's review article.
    Klein HO
    Cell Tissue Kinet; 1980 Jul; 13(4):425-34. PubMed ID: 7000360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the so-called "synchronization therapy" of tumors with vincristine.
    Schultze B; Jellinghaus W; Basler U; Dettmer J; Maurer W
    J Cancer Res Clin Oncol; 1983; 105(3):266-74. PubMed ID: 6853589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations on pharmacologic induction of partial synchronization of tumor cell proliferation: its relevance for cytostatic therapy.
    Klein HO; Adler D; Doering M; Klein PJ; Lennartz KJ
    Cancer Treat Rep; 1976 Dec; 60(12):1959-79. PubMed ID: 1026350
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of nitrogen derivative of verrucarin E, VER-I, on biology and development of morphological, histochemical and histoenzymatic changes in experimental neoplasms in animals].
    Jodczyk KJ
    Patol Pol; 1984; 35(3):349-64. PubMed ID: 6535083
    [No Abstract]   [Full Text] [Related]  

  • 14. [A source of failure in synchronization experiments using malignant tumours in vivo (author's transl)].
    Granzow C; Granzow V
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974 Mar; 81(1):15-22. PubMed ID: 4275053
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell kinetics after vincristine treatment of C3H/He spontaneous mammary tumors: implications for therapy.
    Braunschweiger PG; Schiffer LM
    J Natl Cancer Inst; 1978 May; 60(5):1043-8. PubMed ID: 642025
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy after synchronization of tumor cells.
    Klein HO; Lennartz KJ
    Semin Hematol; 1974 Apr; 11(2):203-27. PubMed ID: 4822988
    [No Abstract]   [Full Text] [Related]  

  • 17. Fetal calf serum and epidermal growth factor prevent the inhibitory action of a chalone-like growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro.
    Lehmann W; Graetz H; Widmayer R; Langen P
    Biomed Biochim Acta; 1984; 43(7):971-4. PubMed ID: 6240265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cell division and changes of the duration of mitosis in murine Ehrlich ascites carcinoma after a single administration of chalone-containing extract from this tumor].
    Romanov IuA; Semenova MV
    Biull Eksp Biol Med; 1982 Mar; 93(3):81-3. PubMed ID: 6212091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
    Grau C; Overgaard J
    Cancer Chemother Pharmacol; 1992; 30(4):277-80. PubMed ID: 1643695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Localized irradiation on tumors and immune cell reactions--histoenzymatic evaluation using MM 46 tumor and Ehrlich tumor-bearing C3H/He mice].
    Imanaka K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb; 43(2):355-69. PubMed ID: 6866746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.